ACTO Achieves Veeva Gold Product Partner Status After Nearly A Decade-Long Commitment
ACTO Wins Veeva Gold Product Partner Recognition
In a significant milestone for the company, ACTO has announced its achievement of the Veeva Gold Product Partner status, an accolade that acknowledges nearly ten years of collaboration aimed at enhancing customer success within the life sciences industry. The announcement was made on September 2, 2026, during a press release by ACTO, a company that integrates human intelligence with empathetic AI to push forward innovation and customer engagement in this critical sector.
ACTO has been a member of the Veeva Product Partner Program since 2017, initially earning the recognition of Silver Product Partner in 2021 and progressing to AI Partner in 2024. This comprehensive journey underscores ACTO's unwavering commitment to improving the effectiveness of field teams, compliance standards, and customer retention strategies in the pharmaceutical and biotech industries.
The Importance of This Milestone
Streamlining Operations and Elevating Standards
The elevation to Veeva Gold Product Partner signifies ACTO's enhanced integration with Veeva's ecosystem, providing life sciences teams with access to a wealth of approved content and real-time operational insights that are vital for successful outreach to healthcare professionals. Through validated integrations with various Veeva products such as Veeva PromoMats, Veeva MedComms, and Veeva Vault CRM, ACTO facilitates a seamless learning environment for companies striving to maintain high standards of compliance while maximizing their field effectiveness.
Parth Khanna, CEO of ACTO, emphasized the significance of this partnership: “With each product launch and indication expansion, field teams must stay ahead of the latest approved content to engage healthcare professionals expertly and accurately.” He further noted that this partnership has allowed for deep integration of ACTO into the daily systems relied upon by clients to ensure operational excellence and compliance at scale.
AI-Powered Solutions for Enhanced Engagement
ACTO's AI-powered field excellence platform designs tailored solutions that cater specifically to customer-facing teams in life sciences. The platform includes features like AI-simulated role-playing, which assists sales representatives in practicing conversations with healthcare professionals using approved messaging and promotional materials from Veeva’s resources. It enables professionals to enhance their skills and ensure they deliver well-informed, impactful communications.
With offerings like ACTO Talk TRx, users gain access to current and approved contents stored within Veeva systems, equipped with essential talking points and best practices for effective engagement.
Looking to the Future
As ACTO embraces this new status, the company is committed to leveraging its partnership with Veeva to enhance corporate readiness, operational efficiency, and customer loyalty across the life sciences spectrum. ACTO's solutions work to combine training, coaching, field activities, and AI workflows integrated with trusted corporate content and data.
Veeva’s Vice President of Alliances, Kristin Peck, acknowledged ACTO's efforts, stating, “Attaining Veeva Gold Product Partner status reflects ACTO’s continuous commitment to delivering Veeva-validated, integrated solutions for the life sciences industry.”
For more insights about how ACTO and Veeva collaborate to improve readiness in the field and operational efficiency, interested parties are encouraged to reach out for information or visit ACTO at the upcoming Fierce PharmaWeek in Philadelphia, which takes place from September 14 to 17.
About ACTO
ACTO has emerged as a trusted partner for 14 of the top 50 pharmaceutical companies, dynamic biotech firms, and leading medical device manufacturers. By redefining how therapies reach patients post-approval, ACTO blends human intelligence with empathetic AI through its AI-powered Field Excellence Platform and AI SuperAgents. This innovative approach aims to accelerate product launches while improving on-the-ground execution and deepening customer engagement.
With industry-compliant standards, including FDA 21 CFR Part 11 validation and SOC 2 Type II certification, ACTO continues to pave the way for transformative practices in the life sciences sector. For more information about ACTO, visit their website at www.acto.com.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.